British HIV Association guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus 2010.
Brook
G
G
British HIV Association (BHIVA), BHIVA Secretariat, Mediscript Ltd, London, UK. gary.brook@nwlh.nhs.uk
Main
J
J
Nelson
M
M
Bhagani
S
S
Wilkins
E
E
Leen
C
C
Fisher
M
M
Gilleece
Y
Y
Gilson
R
R
Freedman
A
A
Kulasegaram
R
R
Agarwal
K
K
Sabin
C
C
Deacon-Adams
C
C
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000601:surgery; D002648:Child; D019317:Evidence-Based Medicine; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000628:therapy; D019694:Hepatitis B, Chronic / Q000150:complications / Q000628:therapy; D019698:Hepatitis C, Chronic / Q000150:complications / Q000628:therapy; D003699:Hepatitis D / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology; D006518:Hepatitis Viruses / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D016233:Immunotherapy, Active / Q000379:methods; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000601:surgery; D016031:Liver Transplantation; D008297:Male
D000998:Antiviral Agents